High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|162|2|282-285

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.162, Iss.2, 2013-07, pp. : 282-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Unusual Myelodysplastic Syndrome with the Initial Presentation Mimicking Idiopathic Thrombocytopenic Purpura

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 139-143

Karger

Access to resources Recommend Favorite

Eosinophilic Pustular Folliculitis (Ofuji's Disease) in Myelodysplastic Syndrome

By  

THE JOURNAL OF DERMATOLOGY, Vol. 25, Iss. 11, 1998-11 ,pp. : 742-746

John Wiley & Sons Inc

Access to resources Recommend Favorite

High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma

By  

CLINICAL ENDOCRINOLOGY, Vol. 300-0664, Iss. 4, 2015-10 ,pp. : 572-580

John Wiley & Sons Inc

Access to resources Recommend Favorite

High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 4, 2015-10 ,pp. : 572-580

John Wiley & Sons Inc

Access to resources Recommend Favorite